Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Current or prospective ownership or investment interest | $304,593 | 5 | 100.0% |
| Food and Beverage | $70.10 | 4 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Pacira Pharmaceuticals Incorporated | $304,593 | 5 | $0 (2021) |
| Janssen Pharmaceuticals, Inc | $45.04 | 3 | $0 (2022) |
| VERTEX PHARMACEUTICALS INCORPORATED | $25.06 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $25.06 | 1 | VERTEX PHARMACEUTICALS INCORPORATED ($25.06) |
| 2022 | $13.34 | 1 | Janssen Pharmaceuticals, Inc ($13.34) |
| 2021 | $33,623 | 3 | Pacira Pharmaceuticals Incorporated ($33,592) |
| 2020 | $62,791 | 2 | Pacira Pharmaceuticals Incorporated ($62,791) |
| 2019 | $208,210 | 2 | Pacira Pharmaceuticals Incorporated ($208,210) |
All Payment Transactions
9 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/06/2024 | VERTEX PHARMACEUTICALS INCORPORATED | — | Food and Beverage | In-kind items and services | $25.06 | General |
| 05/06/2022 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $13.34 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 12/17/2021 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $17.71 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 10/22/2021 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $13.99 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 06/01/2021 | Pacira Pharmaceuticals Incorporated | Iovera System (Device) | Current or prospective ownership or investment interest | In-kind items and services | $33,591.61 | General |
| Category: Pain Management | ||||||
| 05/01/2020 | Pacira Pharmaceuticals Incorporated | IOVERA SYSTEM (Device) | Current or prospective ownership or investment interest | Cash or cash equivalent | $46,084.02 | General |
| Category: PAIN MANAGEMENT | ||||||
| 02/01/2020 | Pacira Pharmaceuticals Incorporated | IOVERA SYSTEM (Device) | Current or prospective ownership or investment interest | Cash or cash equivalent | $16,706.91 | General |
| Category: PAIN MANAGEMENT | ||||||
| 04/09/2019 | Pacira Pharmaceuticals Incorporated | EXPAREL (Drug) | Current or prospective ownership or investment interest | Cash or cash equivalent | $184,820.71 | General |
| Category: PAIN MANAGEMENT | ||||||
| 04/09/2019 | Pacira Pharmaceuticals Incorporated | EXPAREL (Drug) | Current or prospective ownership or investment interest | Cash or cash equivalent | $23,389.68 | General |
| Category: PAIN MANAGEMENT | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 1 | 24 | 25 | $6,775 | $1,567 |
| 2022 | 3 | 72 | 146 | $41,738 | $10,256 |
| 2021 | 2 | 43 | 126 | $39,254 | $10,135 |
| 2020 | 4 | 142 | 240 | $76,683 | $18,764 |
All Medicare Procedures & Services
10 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 24 | 25 | $6,775 | $1,567 | 23.1% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 19 | 76 | $24,168 | $6,142 | 25.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 41 | 42 | $11,382 | $2,524 | 22.2% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 12 | 28 | $6,188 | $1,590 | 25.7% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 23 | 106 | $33,608 | $8,668 | 25.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 20 | 20 | $5,646 | $1,467 | 26.0% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 32 | 118 | $37,524 | $9,683 | 25.8% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 23 | 27 | $16,686 | $4,437 | 26.6% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 69 | 73 | $17,593 | $3,356 | 19.1% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 18 | 22 | $4,880 | $1,289 | 26.4% |
About Tracey Henry
Tracey Henry is a Internal Medicine healthcare provider based in Atlanta, Georgia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/06/2011. The National Provider Identifier (NPI) number assigned to this provider is 1710279955.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Tracey Henry has received a total of $304,663 in payments from pharmaceutical and medical device companies, with $25.06 received in 2024. These payments were reported across 9 transactions from 3 companies. The most common payment nature is "Current or prospective ownership or investment interest" ($304,593).
As a Medicare-enrolled provider, Henry has provided services to 281 Medicare beneficiaries, totaling 537 services with total Medicare billing of $40,723. Data is available for 4 years (2020–2023), covering 10 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Other Specialties Internal Medicine, Internal Medicine
- Location Atlanta, GA
- Active Since 05/06/2011
- Last Updated 04/18/2016
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1710279955
Products in Payments
- EXPAREL (Drug) $208,210
- IOVERA SYSTEM (Device) $62,791
- Iovera System (Device) $33,592
- XARELTO (Drug) $45.04
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Atlanta
Dr. Nitin Gupta, M.d, M.D
Internal Medicine — Payments: $1.2M
Dr. Zandraetta Tims-Cook, Md, Mph, MD, MPH
Internal Medicine — Payments: $648,799
Brian Pearlman, Md, MD
Internal Medicine — Payments: $588,483
Michael Lloyd, Md, MD
Internal Medicine — Payments: $276,236
Mr. Robert Springer, M.d, M.D
Internal Medicine — Payments: $243,195
Dr. Ebon Bourne, M.d, M.D
Internal Medicine — Payments: $196,841